Molecular targets of the present clinical molecules are not known. The latest studies6 determined the proteasome being a promising On this context, some users of MAPK household have now been validated as prospective targets. Among these, is Lmx brucei mutants that overexpress identified important protein kinases, and discovered CLK1 like https://bobd443qcm6.vigilwiki.com/user